Figure 3

In vitro effects of thalidomide on HPAECs.
(A) HPAECs migration assays after various treatments; (B) various mRNA expression in HPAECs’ cell lysates; (C) angiogenic, (D) migration index in co-cultivation of CD16+ monocyte from different rats with HPAECs or system of co-incubated HPAECs with supernatant of co-cultured CD16+ monocyte + HPAECs; (E) ratio of mRNA expressions in co-cultured CD16+ monocyte+HPAECs to those in mono-cultured HPAECs. #,##p < 0.05, 0.01 vs. S-V; *p < 0.05 vs. BDL-V; δp < 0.05 vs. TNFα groups; †p < 0.05 vs. TNFα+thalidomide (thal) groups.